U.S. Neurovascular Devices Industry

The U.S. neurovascular devices market size was valued at USD 693.92 million in 2023 and is projected to grow at a CAGR of 4.90% from 2024 to 2030. Increasing prevalence of neurovascular disorders such as stroke & brain aneurysms along with the rising demand for minimally invasive neurological procedures are responsible for the market growth. Moreover, well-established healthcare infrastructure and favorable reimbursement & regulatory policies in the country create significant growth opportunities in this market.

The growth can be attributed to the increasing prevalence of neurovascular devices, increasing awareness programs by the government and non-government organizations, and an increase in training programs. There are various initiatives undertaken by the government worldwide to prevent stroke. Moreover, the FDA has been collaborating with neurological device manufacturers and professional societies, such as the NeuroPoint Alliance and the National Institutes of Health (NIH) (StrokeNet), with the aim to develop robust registries for the use of generating data for premarket and post-market application and surveillance.

Gather more insights about the market drivers, restrains and growth of the U.S. Neurovascular Devices market

Poor or unhealthy lifestyle choices such as alcohol addiction & smoking are among major factors leading to the development of arterial ischemic stroke (AIS), and the incidence of strokes is increasing every year. Brain strokes are commonly caused due to high blood pressure and weakened blood vessels. For instance, in the U.S., around 795,000 stroke cases occur every year, out of which 23.0% are fatal or cause permanent disability. Moreover, smoking, hypertension, drug abuse, heavy alcohol consumption, and older age are considered major risk factors for brain aneurysms. Thus, increasing adoption of unhealthy lifestyles is likely to boost the growth of the neurovascular devices market.

U.S. accounted for 24.0% of the global neurovascular devices market in 2023. Furthermore, according to the Brain Aneurysm Foundation, more than 6.5 million people in the U.S. have an unruptured brain aneurysm. The brain aneurysm is predominantly found in women aged above 55 than men with a ratio of 3:2, respectively. Moreover, 500,000 deaths occur due to brain rupture every year globally. The continuous introduction of technologically advanced system for treating intracranial aneurysms is also expected to propel the market growth.

Favorable initiatives undertaken by private and public sectors related to neurovascular devices are likely to boost market growth. For instance, the Brain Aneurysm Foundation organized Advocacy Day on Capitol Hill in March 2020 to raise awareness and impart relevant knowledge regarding neurovascular devices. Favorable reimbursement policies by Centers for Medicare and Medicaid Services (CMS) and Musculoskeletal Clinical Regulatory Advisors, LLC (MCRA), among others allow reimbursement of neurovascular devices when ordered by doctors or provided as a part of a physician’s services.

U.S. Neurovascular Devices Market Report Segmentation

  • Device Outlook (Revenue USD Million; Volume Unit; 2018 - 2030)
    • Cerebral Embolization and Aneurysm Coiling Devices
      • Embolic coils
      • Flow diversion devices
      • Liquid embolic agents
    • Cerebral Angioplasty and Stenting Systems
      • Carotid artery stents
      • Embolic protection
    • Neurothrombectomy Devices
      • Clot retrieval devices
      • Suction devices/aspiration catheters
      • Vascular snares
    • Support Devices
      • Micro catheters
      • Micro guidewires
    • Trans Radial Access Devices
  • Therapeutic Application Outlook (Revenue USD Million; 2018 - 2030)
    • Stroke
    • Cerebral Artery
    • Cerebral Aneurysm
      • Aneurysmal Subarachnoid Hemorrhage
      • Others
    • Others
  • Size (in Inches) Outlook (Revenue USD Million; 2018 - 2030)
    • 027"
    • 021"
    • 071"
    • 017"
    • 019"
    • 013"
    • 058"
    • 068"
    • Others
  • End-use Outlook (Revenue USD Million; 2018 - 2030)
    • Hospitals
    • Specialty Clinics
    • Others

Key U.S. Neurovascular Devices Company Insights

Some of the prominent U.S. neurovascular devices market companies are Medtronic, Inc.; Stryker Corporation; Integra LifeSciences and Microvention Inc. and Penumbra Inc. These players are increasingly focusing on product launches, and other growth strategies, such as mergers & acquisitions to strengthen their foothold in the market.

Market players are making constant efforts to introduce technologically advanced products in the market. For instance, in October 2022, Medtronic plc launched a platform that is designed to accelerate the urgent requirement for innovation in stroke care and treatment. The platform has been named Neurovascular Co-lab.

Key U.S. Neurovascular Devices Companies:

  • Medtronic
  • Johnson and Johnson Services Inc.
  • Penumbra, Inc.
  • Microport Scientific Corporation
  • Stryker
  • Microvention Inc (Terumo Corporation)
  • Codman Neuro (Integra Lifesciences)

Recent Developments

  • In February 2024, Philips announced the launch of the Azurion neuro biplane system which is a major enhancement to Azurion, which is its image-guided therapy system. This is designed to help run neurovascular procedures smoothly, allow care teams to make effective decisions faster, and attend to more patients
  • In May 2022, Medtronic acquired Intersect ENT, which is an ENT medical leader. This acquisition is aimed at expanding the company’s product portfolio used for ENT procedures
  • In April 2022, Medtronic and GE Healthcare collaborated to provide care at Office-Based Labs (OBLs) and Ambulatory Surgery Centers (ASCs). This partnership between major industry players is to cater to the rising needs for outpatient care

Order a free sample PDF of the U.S. Neurovascular Devices Market Intelligence Study, published by Grand View Research.